Elanco Animal Health- Units ( Purchase Contract & Senior Amortizing Note) Profit Margin

Elanco Animal Health- Units ( Purchase Contract & Senior Amortizing Note) (ELAT) currently reports a profit margin of -4.95% as of March 2026. That compares with 17.55% in the prior-year period — down 128.2% year over year. That is below the Healthcare sector average of 15.58%. Use the charts on this page to explore Elanco Animal Health- Units ( Purchase Contract & Senior Amortizing Note)'s profit margin history and peer comparisons.

Elanco Animal Health- Units ( Purchase Contract & Senior Amortizing Note)'s profit margin decreased from 17.55% to -4.95% — a 128.2% year-over-year decrease (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Elanco Animal Health- Units ( Purchase Contract & Senior Amortizing Note)'s profit margin of -4.95% is lower than the Healthcare sector average of 15.58%. That is roughly 131.7% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Elanco Animal Health- Units ( Purchase Contract & Senior Amortizing Note)'s current -4.95% should be judged against Healthcare norms (sector average: 15.58%) and against ELAT's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of -4.95%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 15.58%. From there, open related valuation or income-statement pages for Elanco Animal Health- Units ( Purchase Contract & Senior Amortizing Note), and consider following ELAT for alerts when major investors trade the stock.